Results 181 to 190 of about 18,447 (220)

Molecular targets of cannabinoids and their derivatives in epilepsy - a review with focus on CBD. [PDF]

Acta Biochim Pol
Marciniak S, Wasyluk W, Wojtak A.
europepmc   +1 more source

[Partial epilepsy in AIDS].

Medicina, 1995
openaire   +1 more source

Entropy of the resting state cortex in epilepsy

Kaur K, O’Brien-Cairney J, Singh G, Upadhya M, Chakraborty A, Chandra SP, Prüss H, Kornau H, Schmitz D, Woodhall G, Rosch R, Angelova M, Seri S, Tripathi M, Wright SK, Witton C.   +15 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Facial Asymmetry in Partial Epilepsies

Epilepsia, 1992
Summary: Fifty‐six consecutive epileptic patients with partial seizures (30 temporal, 26 extratemporal) and facial asymmetry were studied. Facial asymmetry was compared with EEG, radiologic, and other clinical findings. Thirty patients had a lesional epilepsy whereas 26 were considered cryptogenic.
TINUPER P, PLAZZI G, PROVINI F, CERULLO A, LEONARDI M, AGATI R, RIGHINI A, MONTAGNA P   +7 more
openaire   +3 more sources

Interview accuracy in partial epilepsy

Epilepsy & Behavior, 2009
The statistical concept of accuracy has never been applied to verify the history data collected on seizure disorders by open format interview. We compared patients'/witnesses' descriptions of epileptic seizures with videotaped seizure characteristics and analyzed the accuracy (ACC), sensitivity (SN), specificity (SP), false-positive rate (FPR), and ...
Ana Gabriela, Besocke, Juan Ignacio, Rojas, Stella Maris, Valiensi, Edgardo, Cristiano, María del Carmen, Garcia   +4 more
openaire   +2 more sources

Vigabatrin for refractory partial epilepsy

Cochrane Database of Systematic Reviews, 2008
Epilepsy is a common neurological condition which affects between 0.5% and 1% of the population. Approximately 30% of people with epilepsy do not respond to treatment with currently available drugs, and the majority of these people have partial epilepsy. Vigabatrin is an antiepileptic drug licensed for use in the treatment of refractory epilepsy.
Karla, Hemming, Melissa J, Maguire, Jane L, Hutton, Anthony G, Marson   +3 more
openaire   +3 more sources

Felbamate in refractory partial epilepsy

Epilepsy Research, 1999
This open-label study was performed to evaluate efficacy and safety of Felbamate (FBM) add-on therapy in drug-refractory partial epilepsy. We evaluated 36 patients (12 males) aged 11-68 years (mean 29.8) in which FBM was titrated gradually from 300 mg/day to a mean total maintenance daily dose of 1936 mg.
R. Canger, A. Vignoli, BONARDI, DANIELA RITA, L. Guidolin   +3 more
openaire   +2 more sources

Benign partial epilepsies in infancy

Brain and Development, 2000
Benign partial epilepsies are not rare in infancy and comprise two forms, although both are closely related. One is partial epilepsy with complex partial seizures (CPS) and the other one with secondarily generalized seizures (SGS). The most frequent site of seizure origin was in the temporal area in the former and central, parietal or occipital area in
K, Watanabe, A, Okumura
openaire   +2 more sources

Partial epilepsy with “ecstatic” seizures

Epilepsy & Behavior, 2003
Reports focusing on auras of ecstasy or pleasure have been limited largely to single case descriptions. We examined 11 consecutive patients with such ictal symptoms. Eight had sensory hallucinations, four had erotic sensations, five described "a religious/spiritual experience," and several had symptoms that were felt to have no counterpart in human ...
Bjørn, Asheim Hansen, Eylert, Brodtkorb
openaire   +2 more sources